Skip to main content
Log in

EU-AIMS: a boost to autism research

  • Comment
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

Abstract

A €30 million initiative bringing together academic centres, industry, charities and patient groups provides an unprecedented opportunity for translational research on autism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Baudouin, S. J. et al. Shared synaptic pathophysiology in syndromic and nonsyndromic rodent models of autism. Science 338, 128–132 (2012).

    Article  CAS  Google Scholar 

  2. Kong, A. et al. Rate of de novo mutations and the importance of father's age to disease risk. Nature 488, 471–475 (2012).

    Article  CAS  Google Scholar 

  3. Daly, E. M. et al. Serotonin and the neural processing of facial emotions in adults with autism: an fMRI study using acute tryptophan depletion. Arch. Gen. Psych. 69, 1003–1013 (2012).

    Article  Google Scholar 

  4. Ecker, C., Spooren, W. & Murphy, D. G. M. Translational approaches to the biology of autism: false dawn or a new era? Mol. Psychiatry 17 Jul 2012 (doi:10.1038/mp.2012.102).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Will Spooren.

Ethics declarations

Competing interests

W.S. is an employee of Roche.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Murphy, D., Spooren, W. EU-AIMS: a boost to autism research. Nat Rev Drug Discov 11, 815–816 (2012). https://doi.org/10.1038/nrd3881

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd3881

  • Springer Nature Limited

This article is cited by

Navigation